Korsana Biosciences, Inc. (KRSA)
30.74
-0.54
(-1.73%)
USD |
NASDAQ |
Nov 13, 10:17
Korsana Biosciences Free Cash Flow (Quarterly) : -47.06M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -47.06M |
| June 30, 2026 | -1.432M |
| March 31, 2026 | -1.242M |
| December 31, 2025 | -1.579M |
| September 30, 2025 | -10.33M |
| June 30, 2025 | -0.503M |
| March 31, 2025 | -0.968M |
| December 31, 2024 | 0.36M |
| September 30, 2024 | -1.716M |
| June 30, 2024 | -1.106M |
| March 31, 2024 | -1.871M |
| December 31, 2023 | -1.541M |
| September 30, 2023 | -6.935M |
| June 30, 2023 | -6.555M |
| March 31, 2023 | -6.214M |
| December 31, 2022 | -7.043M |
| September 30, 2022 | -9.915M |
| June 30, 2022 | -10.82M |
| Date | Value |
|---|---|
| March 31, 2022 | -12.84M |
| December 31, 2021 | -8.63M |
| September 30, 2021 | -7.93M |
| June 30, 2021 | -5.509M |
| March 31, 2021 | -14.46M |
| December 31, 2020 | -14.08M |
| September 30, 2020 | -15.06M |
| June 30, 2020 | -14.30M |
| March 31, 2020 | -30.58M |
| December 31, 2019 | -22.34M |
| September 30, 2019 | -24.46M |
| June 30, 2019 | -26.22M |
| March 31, 2019 | -36.08M |
| December 31, 2018 | -24.97M |
| September 30, 2018 | -26.46M |
| June 30, 2018 | -22.92M |
| March 31, 2018 | -26.59M |
| December 31, 2017 | -26.23M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Q32 Bio, Inc. | -4.47M |
| IRulya Therapeutics, Inc. | -18.89M |
| Climb Bio, Inc. | -12.82M |
| PepGen Inc. | -13.18M |
| Bridgebio Oncology Therapeutics, Inc. | -28.38M |